title: Hematological monitoring in patients receiving aminosalicylates.
authors.forename: J C
authors.initials: JC
authors.lastname: Yarze
authors.forename: M P
authors.initials: MP
authors.lastname: Chase
authors.forename: H P
authors.initials: HP
authors.lastname: Fritz
authors.forename: K J
authors.initials: KJ
authors.lastname: Herlihy
mesh_terms: D000284:Administration, Oral; D000285:Administration, Rectal; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016903:Drug Monitoring; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D019804:Mesalamine / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013256:Steroids; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000893:Anti-Inflammatory Agents; D013256:Steroids; D019804:Mesalamine